A Review of the in Vitro and in Vivo Neurochemical Characterization of the NMDA/PCP/glycine/ion Channel Receptor Macrocomplex

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 1990 Feb 1

PMID 2159127

Citations 3

Authors

P L Wood

T S Rao

S Iyengar

T Lanthorn

J Monahan

A Cordi

E Sun

M Vazquez

N Gray

P Contreras

Affiliations

Soon will be listed here.

Citing Articles

Effect of dexamethasone treatment on maturational changes in the NMDA receptor in sheep brain.

McGowan J, Sysyn G, Petersson K, Sadowska G, Mishra O, Delivoria-Papadopoulos M J Neurosci. 2000; 20(19):7424-9.

PMID: 11007901 PMC: 6772773.

Modification of modulatory sites of NMDA receptor in the fetal guinea pig brain during development.

Mishra O, Delivoria-Papadopoulos M Neurochem Res. 1992; 17(12):1223-8.

PMID: 1361031 DOI: 10.1007/BF00968404.

NMDA receptor modification in the fetal guinea pig brain during hypoxia.

Mishra O, Delivoria-Papadopoulos M Neurochem Res. 1992; 17(12):1211-6.

PMID: 1361030 DOI: 10.1007/BF00968402.

References

Snell L, Johnson K . Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J Pharmacol Exp Ther. 1985; 235(1):50-7. View

Wood P, Rao T . NMDA-coupled and uncoupled forms of the PCP receptor: preliminary in vivo evidence for PCP receptor subtypes. Prog Neuropsychopharmacol Biol Psychiatry. 1989; 13(3-4):519-23. DOI: 10.1016/0278-5846(89)90140-1. View

Lehmann J, Hutchison A, McPherson S, Mondadori C, Schmutz M, Sinton C . CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J Pharmacol Exp Ther. 1988; 246(1):65-75. View

Greenberg D, Marks S . Cation interactions with putative NMDA receptor-gated channels labeled by [3H]MK-801 in rat cerebral cortex. Neurosci Lett. 1988; 95(1-3):236-40. DOI: 10.1016/0304-3940(88)90663-5. View

Jones S, Snell L, Johnson K . Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release. J Pharmacol Exp Ther. 1987; 240(2):492-7. View

Davies S, Martin D, MILLAR J, Aram J, Church J, Lodge D . Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands. Eur J Pharmacol. 1988; 145(2):141-51. DOI: 10.1016/0014-2999(88)90225-7. View

Shalaby I, Chenard B, Prochniak M . Glycine reverses 7-Cl kynurenate blockade of glutamate neurotoxicity in cell culture. Eur J Pharmacol. 1989; 160(2):309-11. DOI: 10.1016/0014-2999(89)90506-2. View

Stephens D, Meldrum B, WEIDMANN R, Schneider C, Grutzner M . Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?. Psychopharmacology (Berl). 1986; 90(2):166-9. DOI: 10.1007/BF00181234. View

Sekiguchi M, Okamoto K, Sakai Y . NMDA-receptors on Purkinje cell dendrites in guinea pig cerebellar slices. Brain Res. 1987; 437(2):402-6. DOI: 10.1016/0006-8993(87)91661-1. View

10.

Wood P, Richard J, Pilapil C, Nair N . Antagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellum. Neuropharmacology. 1982; 21(12):1235-8. DOI: 10.1016/0028-3908(82)90126-5. View

11.

Carter C, Benavides J, Legendre P, Vincent J, Noel F, Thuret F . Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther. 1988; 247(3):1222-32. View

12.

van Dorsser W, Barris D, Cordi A, Roba J . Anticonvulsant activity of milacemide. Arch Int Pharmacodyn Ther. 1983; 266(2):239-49. View

13.

ffrench-Mullen J, Hori N, Carpenter D . A comparison of the effects of quinolinate and N-methyl-aspartate on neurons in rat piriform cortex. Neurosci Lett. 1986; 63(1):66-70. DOI: 10.1016/0304-3940(86)90014-5. View

14.

Snell L, Morter R, Johnson K . Glycine potentiates N-methyl-D-aspartate-induced [3H]TCP binding to rat cortical membranes. Neurosci Lett. 1987; 83(3):313-7. DOI: 10.1016/0304-3940(87)90106-6. View

15.

Schwarcz R, Kohler C . Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci Lett. 1983; 38(1):85-90. DOI: 10.1016/0304-3940(83)90115-5. View

16.

Ascher P, Bregestovski P, Nowak L . N-methyl-D-aspartate-activated channels of mouse central neurones in magnesium-free solutions. J Physiol. 1988; 399:207-26. PMC: 1191660. DOI: 10.1113/jphysiol.1988.sp017076. View

17.

Danysz W, Fadda E, Wroblewski J, Costa E . Kynurenate and 2-amino-5-phosphonovalerate interact with multiple binding sites of the N-methyl-D-aspartate-sensitive glutamate receptor domain. Neurosci Lett. 1989; 96(3):340-4. DOI: 10.1016/0304-3940(89)90402-3. View

18.

Hafner D, Heinen E, Noack E . Mathematical analysis of concentration-response relationships. Method for the evaluation of the ED50 and the number of binding sites per receptor molecule using the logit transformation. Arzneimittelforschung. 1977; 27(10):1871-3. View

19.

Wardley-Smith B, Meldrum B, Halsey M . The high pressure neurological syndrome and 2-amino-7-phosphonoheptanoic acid: differences between fed and fasted rats. Neurosci Lett. 1984; 48(2):155-60. DOI: 10.1016/0304-3940(84)90012-0. View

20.

Nicoletti F, Wroblewski J, Costa E . Magnesium ions inhibit the stimulation of inositol phospholipid hydrolysis by endogenous excitatory amino acids in primary cultures of cerebellar granule cells. J Neurochem. 1987; 48(3):967-73. DOI: 10.1111/j.1471-4159.1987.tb05611.x. View